Viewing Study NCT04984434


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2025-12-29 @ 3:52 AM
Study NCT ID: NCT04984434
Status: UNKNOWN
Last Update Posted: 2021-07-30
First Post: 2021-07-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: Shandong New Time Pharmaceutical Co., LTD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module